Organization
Department of Pulmonology, Akershus University Hospital
1 abstract
Abstract
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).Org: Norwegian University of Science and Technology (NTNU), Department of Thoracic Medicine, Haukeland University Hospital, Department of Oncology, Oslo University Hospital, Oslo, Oslo, Norway, Stavanger University Hospital, Department of Oncology, Odense University Hospital,